Source: International Congress 2019 – ALERT: Abstracts Leading to Evolution in Respiratory Medicine Trials: Asthma
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Sridhar (Gaithersburg, MD, United States of America), W. Zhao (Gaithersburg, MD, United States of America), T. Pham (Gaithersburg, MD, United States of America), J. Kearley (Gaithersburg, MD, United States of America), W. White (Gaithersburg, MD, United States of America), Y. Wu (Gaithersburg, MD, United States of America), J. Parnes (Thousand Oaks, CA, United States of America), L. Roskos (Gaithersburg, MD, United States of America), J. Griffiths (Gaithersburg, MD, United States of America). Tezepelumab decreases matrix remodelling and inflammatory pathways in patients with asthma. 3785

Member's Comments

No comment yet.

Related content which might interest you: Differential regulation of inflammatory pathways in alveolar macrophages from COPD patients and smoking controls Source: Annual Congress 2007 - Novel mediators of cellular pathology Year: 2007 The role of small-airway inflammation and remodeling in asthma Source: Annual Congress 2013 –Small airways in asthma: from physiologic measures to clinical relevance Year: 2013 Role of remodelling in asthma Source: Annual Congress 2006 - PG15 - Remodelling and repair in lung disease Year: 2006 IL-33 blockade prevents exacerbations in a model of chronic airway inflammation by blunting persistent inflammation and remodeling Source: International Congress 2019 – Advances in asthma pharmacology Year: 2019 Eosinophils contribute to extracellular matrix remodeling by enhancing pulmonary fibroblasts proliferation, differentiation and extracellular matrix proteins production in asthma Source: International Congress 2018 – Identification of therapeutic targets for asthma Year: 2018 MMPs are regulatory enzymes in pathways of inflammatory disorders, tissue injury, malignancies and remodelling of the lung Source: Eur Respir J 2011; 37: 12-14 Year: 2011 Neurokinins contribute to vascular remodelling in a model of chronic pulmonary allergic inflammation Source: Eur Respir J 2006; 28: Suppl. 50, 760s Year: 2006 Corticosteroids prevent airway remodeling in a mouse model of chronic asthma through TGF-β signaling Source: Eur Respir J 2006; 28: Suppl. 50, 225s Year: 2006 Nlrc5 is involved in allergic airway inflammation and negatively regulates inflammatory signaling pathway via TLR2/NF-?B. Source: International Congress 2018 – Translational models of the immunopathology that underlies airway obstructive diseases Year: 2018 The role of pathological angiogenesis in the pathogenesis of the chronic inflammatory lung diseases Source: Annual Congress 2005 - Update on the role of angiogenesis in the pathogenesis and treatment of lung diseases Year: 2005 Increase in laminin expression in allergic airway remodelling and decrease by dexamethasone Source: Eur Respir J 2004; 24: 107-115 Year: 2004 Infectional factors influences on expressiveness of inflammatory process and structural changes in bronchial mucosa at COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 576s Year: 2006 Are we ready to monitor inflammation and remodelling in asthma? Source: Annual Congress 2005 - Inflammatory phenotypes of asthma and COPD: the end of traditional diagnosis, or not? Year: 2005 Effects of physical stress on lung mechanics, distal airway eosinophilic and lymphocytic inflammation, IL-13 expression and extracellular matrix remodeling in guinea pigs with chronic pulmonary inflammation Source: Annual Congress 2009 - Animal models of airways inflammation Year: 2009 IL-17A is elevated in patients with COPD and contributes to airway remodeling by acting on fibroblasts Source: International Congress 2016 – What's new in biomarker analysis? Year: 2016 Inflammatory cell microlocalisation and airway dysfunction: cause and effect? Source: Eur Respir J 2007; 30: 1043-1056 Year: 2007 Osteopontin expression and relation to disease severity in human asthma Source: Eur Respir J 2011; 37: 331 Year: 2011 Mast cells as key participants in inflammation and remodelling in the respiratory tract Source: Annual Congress 2006 - Mast cells and basophils as key effector cells in airway inflammation and remodelling Year: 2006 Effects of corticosteroid or montelukast associated to iNOS inhibition on inflammation and remodelling of distal lung in animals with chronic inflammation Source: Annual Congress 2010 - Models of airways disease Year: 2010